C-MER MEDICAL (03309) has announced that it repurchased 106,000 shares on September 17, 2026, at a total cost of HK$88,800.
The buyback transaction reflects the company's ongoing capital management strategy, aimed at enhancing shareholder value.
C-MER MEDICAL (03309) has announced that it repurchased 106,000 shares on September 17, 2026, at a total cost of HK$88,800.
The buyback transaction reflects the company's ongoing capital management strategy, aimed at enhancing shareholder value.
Comments